julia
k
veir
dvm
phd
michael
r
lappin
dvm
phd
numer
option
avail
diagnosi
infecti
diseas
felin
medicin
histor
cytolog
techniqu
histopatholog
techniqu
microbiolog
cultur
use
demonstr
presenc
organ
serolog
antibodi
titer
demonstr
immun
respons
infect
howev
techniqu
inher
defici
cytolog
histopatholog
techniqu
requir
organ
larg
enough
seen
microscop
suffici
number
visual
sensit
organ
visual
diagnosi
often
decreas
diseas
progress
host
immun
respons
decreas
number
organ
bodi
microbiolog
cultur
requir
specif
knowledg
organ
requir
growth
may
requir
specif
handl
organ
preserv
cultur
period
longer
clinic
use
immun
respons
organ
demonstr
serum
antibodi
titer
sensit
requir
day
week
host
respons
demonstr
exposur
organ
diseas
secondari
organ
even
current
infect
diagnost
test
practic
must
use
high
sensit
specif
reliabl
reproduc
conveni
costeffect
reason
use
molecular
assay
felin
medicin
gain
favor
diagnosi
diseas
caus
organ
difficult
identifi
detect
cultur
time
fashion
veterinarian
reli
proper
use
molecular
assay
daili
basi
practic
highqual
veterinari
medicin
articl
provid
brief
overview
technolog
avail
shortcom
advantag
current
clinic
applic
technolog
felin
medicin
molecular
assay
reli
detect
nucleic
acid
dna
rna
nucleic
acid
part
genet
makeup
organ
consist
nucleotid
vari
sequenc
mani
portion
dna
rna
highli
conserv
organ
wherea
portion
specif
organ
famili
genu
speci
even
strain
level
sequenc
specif
use
detect
organ
within
clinic
sampl
use
form
complementari
sequenc
sometim
signal
molecul
signal
molecul
often
form
fluoresc
molecul
improv
sensit
simplest
applic
molecular
tool
detect
infecti
organ
use
complementari
nucleic
acid
sequenc
term
probe
tag
fluoresc
molecul
probe
ad
directli
clinic
sampl
either
fluid
tissu
section
multipl
probe
differ
fluoresc
tag
ad
singl
sampl
allow
detect
sever
organ
singl
assay
techniqu
hybrid
probe
target
sequenc
organ
one
first
appli
techniqu
human
clinic
medicin
gain
widespread
use
felin
medicin
techniqu
still
use
routin
monitor
viral
load
patient
infect
human
immunodefici
viru
undergo
antivir
therapi
felin
therapeut
correl
treatment
felin
immunodefici
viru
fiv
advanc
fine
tune
protocol
probe
hybrid
rapid
user
friendli
simpl
perform
techniqu
also
remov
need
special
cultur
condit
sensit
techniqu
poor
compar
molecular
techniqu
prior
enrich
sampl
via
microbiolog
cultur
improv
sensit
increas
time
need
assay
requir
knowledg
microbiolog
cultur
demand
organ
elimin
mani
advantag
techniqu
clinic
applic
techniqu
remain
use
detect
slowgrow
organ
fungi
mycobacteria
presenc
rapidli
grow
organ
cultur
rapid
quantif
organ
load
nonenrich
clinic
sampl
special
applic
probe
hybrid
situ
hybrid
techniqu
use
theori
simpl
probe
hybrid
appli
tissu
sampl
allow
detect
organ
interest
associ
inflammatori
lesion
specif
area
tissu
techniqu
use
situat
larg
number
organ
detect
organ
may
part
normal
flora
gastrointestin
tract
situ
hybrid
allow
user
determin
certain
bacteri
speci
associ
inflamm
beyond
superfici
layer
gastrointestin
tract
fluoresc
molecul
common
signal
mechan
use
case
method
abbrevi
fish
fluoresc
situ
hybrid
technolog
simpl
solutionbas
probe
hybrid
requir
skill
oper
nonspecif
background
stain
caus
falseposit
result
polymeras
chain
reaction
pcr
first
describ
kari
mulli
colleagu
mulli
later
receiv
nobel
prize
chemistri
power
tool
use
cyclic
amplif
strand
dna
use
proprietari
enzym
produc
exponenti
number
ident
copi
detect
level
fig
dna
analyz
usual
gel
determin
predict
size
reaction
see
fig
applic
techniqu
allow
detect
minut
number
organ
small
sampl
advantag
felin
medicin
given
size
patient
pcr
superior
probe
hybrid
techniqu
sensit
amplif
although
exponenti
amplif
origin
target
provid
greatest
advantag
techniqu
also
basi
greatest
downfal
contamin
initi
pcr
restrict
highli
special
research
diagnost
laboratori
commerci
avail
kitbas
visual
use
gel
electrophoresi
size
product
compar
standard
confirm
predict
product
produc
technolog
allow
widespread
use
pcr
technolog
decreas
cost
improv
avail
increas
concern
regard
qualiti
control
strict
adher
good
laboratori
practic
must
observ
credibl
result
criterion
rais
problem
clinician
awar
actual
laboratori
practic
laboratori
suppli
assay
therefor
recommend
recent
publish
pcr
assay
use
clinic
origin
laboratori
use
possibl
laboratori
personnel
familiar
nuanc
individu
assay
experi
largest
number
clinic
sampl
dna
inactiv
organ
inject
bloodstream
laboratori
anim
detect
week
inject
demonstr
high
sensit
techniqu
also
care
must
taken
interpret
result
detect
organ
nucleic
acid
bloodstream
necessarili
mean
activ
infect
diseas
presenc
nucleic
acid
simpli
indic
nucleic
materi
organ
exist
host
organ
aliv
capabl
replic
actual
caus
clinic
sign
host
correl
clinic
sign
known
syndrom
associ
organ
andor
respons
therapi
must
use
conjunct
result
pcr
final
prevent
falseneg
result
sampl
test
obtain
treatment
treatment
may
decreas
organ
load
level
detect
even
pcr
even
though
organ
still
present
host
structur
differ
rna
dna
enzym
use
pcr
duplic
strand
dna
howev
mani
infecti
agent
rna
virus
therefor
preliminari
step
revers
transcript
rt
creat
complementari
strand
dna
target
rna
must
perform
amplif
complementari
dna
via
pcr
perform
method
commonli
known
rtpcr
primer
use
pcr
design
amplifi
nucleic
acid
member
certain
genu
speci
even
strain
detect
suspect
organ
far
common
use
pcr
veterinari
medicin
singl
organ
target
assay
techniqu
term
singleplex
pcr
multipl
target
detect
singl
assay
techniqu
term
multiplex
assay
clearli
advantag
investig
presenc
multipl
organ
singl
assay
howev
pcr
assay
target
sequenc
compet
common
build
block
allow
reaction
proceed
enzym
nucleotid
variou
buffer
ion
therefor
multiplex
reaction
frequent
less
sensit
singleplex
assay
requir
extens
optim
use
specif
organ
identifi
like
caus
clinic
sign
use
broadrang
degener
primer
amplifi
dna
member
entir
genu
even
kingdom
use
target
highli
conserv
region
nucleic
acid
common
applic
pcr
rapid
detect
identif
bacteria
fungi
clinic
sampl
pcr
result
avail
earli
hour
provid
inform
whether
fungal
bacteri
nucleic
acid
present
sampl
subsequ
analysi
pcr
product
may
use
identifi
infect
organ
much
rapidli
tradit
microbiolog
techniqu
may
sensit
detect
fastidi
organ
howev
antimicrobi
sensit
avail
use
techniqu
therefor
pcr
complementari
tradit
cultur
techniqu
howev
use
pcr
veir
lappin
detect
certain
gene
encod
antimicrobi
resist
also
start
gain
clinic
use
may
provid
addit
rapid
inform
antimicrobi
sensit
result
avail
recent
applic
pcr
clinic
felin
medicin
realtim
quantit
pcr
qpcr
quantif
tradit
endpoint
pcr
difficult
mani
amplif
cycl
sampl
yield
essenti
amount
product
limit
reagent
would
complet
consum
final
amplif
cycl
higuchi
colleagu
report
techniqu
monitor
product
dna
amplif
cycl
origin
quantiti
could
extrapol
identif
logarithm
amplif
phase
individu
reaction
techniqu
use
fluoresc
dye
probe
produc
signal
format
product
fig
amplif
cycl
detector
record
amount
fluoresc
sampl
gene
express
commonli
measur
use
qpcr
use
mani
diseas
state
felin
evalu
host
respons
infect
pathogen
detect
load
determin
mani
applic
technolog
assay
advantag
tradit
endpoint
pcr
sensit
specif
offer
rapid
result
abil
quantit
microbi
dna
rna
load
howev
improv
addit
concern
regard
qualiti
control
ad
fluoresc
dye
probe
use
detect
pcr
product
allow
even
sensit
assay
suscept
contamin
lead
falseposit
result
accuraci
quantit
reliant
avail
reproduc
highqual
standard
curv
attempt
regul
rapidli
expand
field
minimum
laboratori
standard
propos
although
guidelin
use
evalu
qualiti
publish
protocol
mani
diagnost
laboratori
use
proprietari
reaction
subject
peer
review
practic
practition
need
request
evalu
data
diagnost
laboratori
evalu
clinic
util
assay
evalu
peerreview
journal
follow
review
assay
current
commerci
avail
felin
medicin
diagnosi
infecti
diseas
anticip
mani
applic
develop
upcom
year
respons
clinician
maintain
knowledg
current
literatur
appli
new
assay
appropri
manner
molecular
assay
simpli
indic
presenc
microbi
dna
rna
diseas
abil
assay
detect
organ
measur
sensit
specif
frequenc
assay
detect
organ
sensit
organ
specif
true
measur
test
diseas
diagnosi
predict
valu
posit
predict
valu
ppv
measur
test
abil
predict
presenc
diseas
neg
predict
valu
npv
abil
assay
predict
absenc
diseas
howev
diagnost
laboratori
report
sensit
specif
easier
calcul
henc
onu
rememb
predict
valu
assay
syndrom
assess
clinician
felin
caliciviru
fcv
infect
common
differenti
diagnosi
cat
clinic
evid
rhiniti
stomat
less
commonli
fcv
infect
associ
conjunct
polyarthr
lower
airway
diseas
kitten
viru
isol
use
document
current
infect
take
least
sever
day
result
return
widespread
exposur
vaccin
ppv
serolog
test
poor
rtpcr
assay
use
amplifi
rna
fcv
result
return
quickli
howev
assay
also
amplifi
vaccin
strain
fcv
fcv
rna
amplifi
sampl
collect
normal
carrier
cat
well
clinic
ill
cat
detect
fcv
rna
poor
ppv
exampl
one
studi
presenc
fcv
rna
fail
correl
presenc
absenc
stomat
cat
addit
amplif
fcv
rna
use
prove
virul
system
caliciviru
infect
result
fcv
rtpcr
also
fals
neg
poor
npv
infect
felin
herpesviru
common
differenti
diagnosi
cat
clinic
evid
rhiniti
stomat
conjunct
kerat
facial
dermat
widespread
exposur
vaccin
ppv
serolog
test
poor
document
direct
fluoresc
stain
conjunctiv
scrape
viru
isol
pcr
dna
amplifi
conjunctiva
nasal
discharg
pharynx
healthi
cat
ppv
convent
pcr
assay
low
current
use
pcr
assay
also
detect
vaccin
strain
lessen
ppv
assay
one
studi
presenc
dna
fail
correl
presenc
absenc
stomat
cat
one
studi
result
qpcr
may
ultim
prove
correl
presenc
absenc
diseas
fail
correl
presenc
conjunct
npv
pcr
assay
also
question
mani
cat
like
diseas
show
neg
result
result
may
relat
clearanc
dna
tissu
hypersensit
reaction
tissu
biopsi
greater
sensit
conjunctiv
swab
necessarili
greater
predict
valu
dna
amplifi
aqueou
humor
cat
whether
amplif
indic
uveiti
unknown
mycoplasma
spp
chlamydophila
feli
bordetella
bronchiseptica
common
respiratori
pathogen
cat
fcv
pcrposit
test
result
use
distinguish
carrier
clinic
ill
cat
addit
pcr
assay
provid
antimicrobi
drug
suscept
test
cat
potenti
bordetellosi
cultur
sensit
optim
diagnost
techniqu
especi
case
outbreak
toxoplasma
gondii
dna
amplifi
airway
wash
cat
lower
respiratori
tract
diseas
pcr
option
evalu
sampl
diseas
anim
organ
identifi
cytolog
detect
giardia
spp
gener
made
combin
fecal
flotat
techniqu
wetmount
examin
fecal
antigen
test
also
accur
sever
assay
avail
pointofcar
use
includ
one
label
veterinari
use
fecal
pcr
assay
often
show
falseneg
result
pcr
inhibitor
stool
pcr
use
screen
procedur
agent
howev
giardia
spp
pcr
assay
use
determin
whether
infect
speci
zoonot
assemblag
primari
indic
techniqu
howev
seem
assemblag
determin
perform
gene
accur
result
although
cryptosporidium
spp
infect
common
unusu
find
cryptosporidium
feli
oocyst
use
fecal
flotat
cat
acidfast
stain
thin
fecal
smear
cumbersom
insensit
antigen
assay
titrat
use
human
fece
inaccur
use
cat
fece
thu
pcr
may
aid
diagnosi
cryptosporidiosi
dog
cat
shown
sensit
immunofluoresc
assay
ifa
cat
cryptosporidium
spp
pcr
assay
indic
ifaneg
cat
unexplain
small
bowel
diarrhea
genotyp
cryptosporidium
determin
howev
cryptosporidium
feli
infect
cat
common
posit
test
result
alway
prove
cryptosporidium
feli
caus
clinic
diseas
drug
known
elimin
cryptosporidium
spp
infect
small
anim
strain
consid
signific
zoonot
agent
pcr
current
indic
healthi
anim
pcr
assay
also
avail
detect
dna
tritrichomona
foetu
salmonella
spp
campylobact
spp
clostridium
spp
parvovirus
gondii
rtpcr
assay
avail
coronavirus
trophozoit
foetu
often
detect
wetmount
examin
fresh
fece
complet
inclin
test
dna
foetu
detect
healthi
carrier
cat
posit
test
result
alway
prove
ill
organ
case
suspect
salmonellosi
campylobacteriosi
assess
done
cultur
rather
pcr
determin
antimicrobi
suscept
pattern
dog
ppv
clostridium
spp
pcr
assay
fece
low
assay
use
combin
enterotoxin
assay
inform
cat
current
lack
present
noevid
parvoviru
pcr
assay
fece
superior
current
avail
antigen
assay
current
use
pcr
assay
panleukopenia
viru
amplifi
vaccin
strain
oocyst
gondii
shed
day
million
oocyst
gener
shed
period
make
organ
easi
identifi
thu
pcr
assay
usual
need
diagnos
infect
viru
isol
clinic
practic
rtpcr
use
frequent
detect
coronaviru
rna
fece
howev
posit
test
result
differenti
felin
infecti
periton
fip
induc
strain
enter
coronavirus
mycoplasma
haemof
mhf
candidatu
mycoplasma
haemominutum
mhm
candidatu
mycoplasma
turicensi
mtc
found
cat
least
studi
experiment
infect
cat
mhf
found
appar
pathogen
mhm
seem
mtc
intermedi
pathogen
diagnosi
base
demonstr
organ
surfac
erythrocyt
examin
thin
blood
film
pcr
assay
number
organ
fluctuat
blood
film
examin
result
fals
neg
time
may
difficult
find
agent
cytolog
particularli
chronic
phase
thu
pcr
assay
test
choic
sensit
primer
amplifi
dna
hemoplasma
avail
qpcr
assay
use
monitor
copi
number
treatment
greater
sensit
specif
predict
valu
convent
pcr
assay
pcr
assay
consid
evalu
cat
unexplain
fever
anemia
cytolog
neg
hemoplasma
addit
american
colleg
veterinari
intern
medicin
recommend
screen
cat
hemoplasma
pcr
assay
use
blood
donor
mani
cat
carrier
rel
nonpathogen
candidatu
mhm
posit
test
result
may
alway
correl
presenc
diseas
poor
ppv
cat
infect
ehrlichia
canislik
organ
anaplasma
phagocytophilum
littl
known
agent
genera
regard
cat
organ
differ
genera
serolog
crossreact
variabl
thu
although
clinic
syndrom
similar
neither
singl
serolog
test
document
infect
standard
serolog
cat
addit
cat
e
cani
infect
seroconvert
pcr
assay
superior
serolog
test
cat
pcr
assay
design
amplifi
nucleic
acid
organ
altern
primer
avail
amplifi
entir
nucleic
acid
organ
singl
reaction
sequenc
use
determin
infect
speci
cat
infect
rickettsia
feli
shown
antibodi
rickettsia
rickettsii
fever
headach
myalgia
macular
rash
human
attribut
r
feli
infect
sever
countri
around
world
studi
pair
cat
blood
flea
extract
alabama
maryland
texa
assay
use
pcr
assay
amplifi
region
citrat
synthas
gene
glta
outer
membran
protein
b
gene
ompb
pair
flea
extract
none
cat
blood
sampl
posit
presenc
r
feli
dna
anoth
studi
antibodi
preval
rate
r
feli
r
rickettsii
shown
respect
cat
fever
neither
dna
amplifi
blood
result
prove
cat
sometim
expos
organ
data
need
determin
signific
diseas
associ
whether
rickettsia
spp
pcr
assay
indic
use
cat
present
unknown
blood
cultur
pcr
assay
blood
serolog
test
use
assess
individu
cat
bartonella
spp
infect
cat
cultur
neg
pcr
neg
antibodi
neg
cat
cultur
neg
pcr
neg
antibodi
posit
probabl
sourc
flea
cat
human
infect
howev
bacteremia
intermitt
falseneg
cultur
pcr
result
occur
limit
predict
valu
singl
batteri
test
although
serolog
test
use
determin
whether
individu
cat
expos
seroposit
seroneg
cat
bacterem
limit
diagnost
util
serolog
test
thu
test
healthi
cat
bartonella
spp
infect
recommend
present
test
reserv
cat
suspect
clinic
bartonellosi
bartonella
spp
infect
common
healthi
cat
even
cultureor
pcrposit
result
prove
clinic
bartonellosi
exampl
although
dna
bartonella
spp
detect
number
cat
fever
pairmatch
cat
without
fever
test
result
healthi
cat
still
commonli
posit
combin
serolog
pcr
ration
approach
evalu
cat
suspect
bartonellosi
cytauxzoon
feli
clinic
affect
cat
usual
easili
identifi
cytolog
examin
blood
smear
splenic
aspir
serolog
test
commerci
avail
pcr
use
amplifi
organ
dna
blood
cat
cytolog
neg
cytauxzoon
feli
antibodi
fiv
detect
serum
clinic
practic
frequent
enzymelink
immunosorb
assay
elisa
comparison
differ
test
shown
result
assay
compar
result
viru
isol
rtpcr
blood
posit
serolog
neg
cat
falseposit
reaction
occur
use
elisa
henc
posit
result
elisa
healthi
lowrisk
cat
confirm
use
western
blot
immunoassay
kitten
detect
colostrumderiv
antibodi
sever
month
kitten
younger
month
fiv
seroposit
test
everi
day
result
neg
antibodi
persist
month
age
kitten
like
infect
viru
isol
rtpcr
blood
also
perform
confirm
infect
howev
fiv
present
blood
high
level
falseneg
test
result
common
thu
assay
accur
distinguish
vaccin
cat
natur
expos
cat
cat
felin
leukemia
viru
infect
virem
molecular
diagnost
assay
usual
need
clinic
practic
howev
newer
sensit
qpcr
assay
use
accur
character
stage
infect
assay
commonli
avail
commerci
rna
fip
viru
felin
enter
coronaviru
fecv
amplifi
blood
cat
posit
test
result
alway
correl
develop
fip
amplif
mrna
messeng
rna
gene
rtpcr
mix
result
studi
perform
date
amplif
logic
approach
theori
found
high
specif
first
report
approach
howev
followup
studi
larger
number
cat
appar
normal
cat
posit
fecv
mrna
blood
suggest
ppv
assay
diagnosi
fip
low
assay
still
avail
commerci
howev
base
publish
data
assay
seem
anymor
clinic
use
molecular
assay
diagnosi
fip
gondii
bartonella
spp
coronaviru
organ
dna
rna
amplifi
frequent
aqueou
humor
cat
endogen
uveiti
although
littl
known
predict
valu
assay
use
aqueou
humor
combin
molecular
assay
local
antibodi
product
indic
may
aid
diagnosi
case
molecular
tool
becom
wide
avail
cost
avail
molecular
assay
becom
access
felin
practition
howev
molecular
diagnosi
rapidli
expand
field
sensit
assay
along
often
high
frequenc
detect
healthi
anim
make
interpret
posit
test
result
difficult
clinician
must
rememb
predict
valu
much
valuabl
tool
assess
util
test
result
particular
anim
